Withdrawal of a new cancer drug manufactured by Roche

Caught in the middle of a tug-of-war between the Roche Group and the Swiss Confederation, Swiss cancer patients find themselves deprived of treatment. The pharmaceutical giant has decided to withdraw its drug Lunsumio from the market, deeming the price proposed by the authorities to be insufficient.